Holen Sie sich die Stockscreener-App
0.2316
2.07%
-0.0049
Handel nachbörslich:
.23
-0.0016
-0.69%
Schlusskurs vom Vortag:
$0.2365
Offen:
$0.2304
24-Stunden-Volumen:
2.96M
Relative Volume:
0.60
Marktkapitalisierung:
$10.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.54M
KGV:
-0.3619
EPS:
-0.64
Netto-Cashflow:
$-22.72M
1W Leistung:
-1.45%
1M Leistung:
-87.68%
6M Leistung:
-86.05%
1J Leistung:
-96.04%
1-Tages-Spanne:
$0.2302
$0.238
1-Wochen-Bereich:
$0.2251
$0.2577
52-Wochen-Spanne:
$0.2222
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
Firmenname
Essa Pharma Inc
Sektor
Branche
Telefon
(778) 331-0962
Adresse
SUITE 720, VANCOUVER, BC
Vergleichen Sie EPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
0.2316 | 11.30M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-04 | Herabstufung | Jefferies | Buy → Hold |
| 2024-11-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-11-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-03-04 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-02 | Eingeleitet | Jefferies | Buy |
| 2019-10-25 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Essa Pharma Inc Aktie (EPIX) Neueste Nachrichten
Risk vs reward if holding onto ESSA Pharma Inc.July 2025 Setups & Weekly Breakout Stock Alerts - Newser
Why ESSA Pharma Inc. is moving todayStop Loss & Technical Pattern Based Signals - Newser
Visual analytics tools that track ESSA Pharma Inc. performanceEntry Point & Community Verified Trade Signals - Newser
What makes ESSA Pharma Inc. stock price move sharply2025 Valuation Update & High Yield Stock Recommendations - Newser
ESSA Pharma Inc. stock trend outlook and recovery pathTrade Analysis Summary & Daily Profit Focused Stock Screening - Newser
Is ESSA Pharma Inc. forming higher highs and higher lows2025 Valuation Update & Detailed Earnings Play Alerts - khodrobank.com
Exit strategy if you’re trapped in ESSA Pharma Inc.Fed Meeting & Technical Confirmation Alerts - Newser
ESSA Pharma Inc. stock volume spike explainedMarket Volume Summary & Real-Time Price Movement Reports - Newser
What high frequency data says about ESSA Pharma Inc.Portfolio Gains Report & Step-by-Step Trade Execution Guides - Newser
Can ESSA Pharma Inc. lead its sector in growthJuly 2025 Weekly Recap & Verified Trade Idea Suggestions - khodrobank.com
Is ESSA Pharma Inc. stock bottoming outShare Buyback & Accurate Entry and Exit Point Alerts - Newser
Price action breakdown for ESSA Pharma Inc.Wall Street Watch & Weekly Top Stock Performers List - Newser
Will ESSA Pharma Inc. see short term momentumPortfolio Risk Summary & Fast Entry Momentum Alerts - Newser
Using economic indicators to assess ESSA Pharma Inc. potential2025 Trading Recap & Daily Entry Point Trade Alerts - Newser
Chart based exit strategy for ESSA Pharma Inc.2025 Price Action Summary & Expert Curated Trade Ideas - Newser
What’s the recovery path for long term holders of ESSA Pharma Inc.Quarterly Market Summary & Weekly Chart Analysis and Trade Guides - Newser
Applying sector rotation models to ESSA Pharma Inc.2025 AllTime Highs & Low Drawdown Investment Strategies - Newser
Volatility clustering patterns for ESSA Pharma Inc.Quarterly Trade Review & Long-Term Safe Investment Ideas - Newser
What drives ESSA Pharma Inc.’s stock priceJuly 2025 Technicals & Free Community Supported Trade Ideas - khodrobank.com
Essa Pharma (EPIX) Nosedives 66% Ahead of Business Shutdown - MSN
Is ESSA Pharma Inc. still worth holding after the dipJuly 2025 Outlook & Stock Portfolio Risk Management - Newser
Is ESSA Pharma Inc. a turnaround storyJuly 2025 Reactions & Weekly High Potential Alerts - khodrobank.com
Is ESSA Pharma Inc. stock a good pick for beginnersWeekly Risk Summary & Fast Entry and Exit Trade Plans - khodrobank.com
Order flow analysis tools used on ESSA Pharma Inc.July 2025 WrapUp & Daily Volume Surge Trade Alerts - Newser
Will ESSA Pharma Inc. continue its uptrendOptions Play & Low Volatility Stock Recommendations - Newser
ESSA Pharma Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EPIX - ACCESS Newswire
ESSA Pharma Inc. Facing Inflection Point in Trend Analysis2025 Market Sentiment & Safe Entry Trade Signal Reports - beatles.ru
How to build a custom watchlist for ESSA Pharma Inc.Exit Point & Stepwise Trade Signal Guides - Newser
Will a bounce in ESSA Pharma Inc. offer an exitPortfolio Update Report & Growth Oriented Trade Recommendations - Newser
Real time pattern detection on ESSA Pharma Inc. stockQuarterly Market Review & Long-Term Growth Portfolio Plans - Newser
Technical analysis overview for ESSA Pharma Inc. stock2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Chart based analysis of ESSA Pharma Inc. trendsRisk Management & Verified Technical Signals - Newser
Finanzdaten der Essa Pharma Inc-Aktie (EPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Essa Pharma Inc-Aktie (EPIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BIOTECH GROWTH N V | 10% Owner |
Nov 01 '24 |
Sale |
1.53 |
7,879,583 |
12,018,409 |
0 |
| Virsik Peter | Chief Operating Officer |
Oct 07 '24 |
Sale |
6.03 |
694 |
4,185 |
7,776 |
| Virsik Peter | Chief Operating Officer |
Sep 09 '24 |
Sale |
6.00 |
694 |
4,164 |
8,470 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):